Juravinski Cancer Centre

Results: 5



#Item
11st-Line Trials Study of Efficacy and Safety of Sunitinib Given on an Individualized Schedule NCT01499121 Tom Baker Cancer Centre Cross Cancer Institute

1st-Line Trials Study of Efficacy and Safety of Sunitinib Given on an Individualized Schedule NCT01499121 Tom Baker Cancer Centre Cross Cancer Institute

Add to Reading List

Source URL: www.kidneycancercanada.ca

Language: English - Date: 2014-10-28 16:21:17
2“Inspiring research – because every patient matters”  Launch Celebration | September 22, 2011 | Program 2

“Inspiring research – because every patient matters” Launch Celebration | September 22, 2011 | Program 2

Add to Reading List

Source URL: www.hhsresearchadmin.ca

Language: English - Date: 2013-09-30 14:12:23
3September[removed]Wellwood presents... PEER SUPPORT: One-on-one peer support, for people who are coping with cancer. By appointment. Support and discussion group for Women with Gynecological Cancer, on the first Wednesday

September[removed]Wellwood presents... PEER SUPPORT: One-on-one peer support, for people who are coping with cancer. By appointment. Support and discussion group for Women with Gynecological Cancer, on the first Wednesday

Add to Reading List

Source URL: www.wellwood.on.ca

Language: English - Date: 2014-08-21 15:26:59
41st-Line Trials Study of Efficacy and Safety of Sunitinib Given on an Individualized Schedule NCT01499121 Tom Baker Cancer Centre Cross Cancer Institute

1st-Line Trials Study of Efficacy and Safety of Sunitinib Given on an Individualized Schedule NCT01499121 Tom Baker Cancer Centre Cross Cancer Institute

Add to Reading List

Source URL: www.kidneycancercanada.ca

Language: English - Date: 2014-08-01 14:55:56
5Microsoft Word - PatientFamilyHandbookJCC-th.doc

Microsoft Word - PatientFamilyHandbookJCC-th.doc

Add to Reading List

Source URL: www.hamiltonhealthsciences.ca

Language: English - Date: 2014-06-17 13:17:36